• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Contribution of Ototoxic Medications to Hearing Loss Among Older Adults.老年人群听力损失与耳毒性药物的相关性。
J Gerontol A Biol Sci Med Sci. 2020 Feb 14;75(3):561-566. doi: 10.1093/gerona/glz166.
2
Prevalence of ototoxic medication use among older adults in Beaver Dam, Wisconsin.威斯康星州比弗代尔老年人中使用耳毒性药物的患病率。
J Am Assoc Nurse Pract. 2018 Jan;30(1):27-34. doi: 10.1097/JXX.0000000000000011.
3
Platinum-induced hearing loss after treatment for childhood cancer.儿童癌症治疗后铂诱导的听力损失。
Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD010181. doi: 10.1002/14651858.CD010181.pub2.
4
Pattern of ototoxicity in a Nigerian teaching hospital.尼日利亚一家教学医院的耳毒性模式。
Niger J Med. 2010 Jul-Sep;19(3):320-3. doi: 10.4314/njm.v19i3.60226.
5
Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.影响畸变产物耳声发射对耳毒性听力损失敏感性的因素。
Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99.
6
Analgesic use and the risk of hearing loss in men.男性镇痛药使用与听力损失风险。
Am J Med. 2010 Mar;123(3):231-7. doi: 10.1016/j.amjmed.2009.08.006.
7
Ototoxic hearing loss from antimalarials: A systematic narrative review.抗疟药导致的耳毒性听力损失:系统叙述性综述。
Travel Med Infect Dis. 2021 Sep-Oct;43:102117. doi: 10.1016/j.tmaid.2021.102117. Epub 2021 Jun 12.
8
The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.根据 2052 项听力学评估结果,与大龄儿童相比,接受顺铂治疗的幼儿的累积听力损失发生率更高,且在治疗早期就开始出现听力损失。
Cancer. 2022 Jan 1;128(1):169-179. doi: 10.1002/cncr.33848. Epub 2021 Sep 7.
9
Prevention and management of hearing loss in patients receiving ototoxic medications.接受耳毒性药物治疗的患者的听力损失预防和管理。
Bull World Health Organ. 2022 Dec 1;100(12):789-796A. doi: 10.2471/BLT.21.286823. Epub 2022 Sep 2.
10
[Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs ].[药物耳毒性。第二部分。袢利尿剂、非甾体抗炎药、抗肿瘤药和抗疟药]
Wiad Lek. 2003;56(7-8):369-74.

引用本文的文献

1
Effects of Methionine and Glutathione on Acute Ototoxicity Induced by Amikacin and Furosemide in an Animal Model of Hearing Threshold Decrease.蛋氨酸和谷胱甘肽对阿米卡星和速尿诱导的动物听力阈值降低急性耳毒性的影响。
Biomedicines. 2025 Jun 15;13(6):1476. doi: 10.3390/biomedicines13061476.
2
Presbycusis: Pathology, Signal Pathways, and Therapeutic Strategy.老年性聋:病理学、信号通路及治疗策略
Adv Sci (Weinh). 2025 Aug;12(29):e2410413. doi: 10.1002/advs.202410413. Epub 2025 May 11.
3
Proton pump inhibitors and risk of hearing loss; a systematic review.质子泵抑制剂与听力损失风险;一项系统评价
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 9. doi: 10.1007/s00210-025-04241-5.
4
Review of Ototoxic Drugs Using Health Insurance Data: A Data-Driven Management System.利用医疗保险数据对耳毒性药物的回顾:一个数据驱动的管理系统
OTO Open. 2025 Apr 25;9(2):e70121. doi: 10.1002/oto2.70121. eCollection 2025 Apr-Jun.
5
Anodal direct current stimulation of the auditory cortex at the onset of presbycusis delays cortical aging.在老年性聋发病时对听觉皮层进行阳极直流电刺激可延缓皮层衰老。
Brain Struct Funct. 2025 Apr 25;230(4):56. doi: 10.1007/s00429-025-02912-w.
6
A disproportionality analysis of adverse events associated with loop diuretics in the FDA Adverse Event Reporting System (FAERS).美国食品药品监督管理局不良事件报告系统(FAERS)中与襻利尿剂相关不良事件的不成比例性分析。
BMC Pharmacol Toxicol. 2025 Mar 17;26(1):63. doi: 10.1186/s40360-025-00890-7.
7
Working behaviors and the risk of sensorineural hearing loss: A large cohort study.工作行为与感音神经性听力损失风险:一项大型队列研究。
Scand J Work Environ Health. 2025 Mar 1;51(2):77-88. doi: 10.5271/sjweh.4209. Epub 2025 Feb 14.
8
Association between hypertension and hearing loss: a systemic review and meta-analysis.高血压与听力损失之间的关联:一项系统评价与荟萃分析。
Front Neurol. 2025 Jan 7;15:1470997. doi: 10.3389/fneur.2024.1470997. eCollection 2024.
9
Age-related hearing loss in older adults: etiology and rehabilitation strategies.老年人与年龄相关的听力损失:病因及康复策略
Front Neurosci. 2024 Oct 1;18:1428564. doi: 10.3389/fnins.2024.1428564. eCollection 2024.
10
Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes.血液透析第一年的利尿剂处方:国际实践模式及与预后的关联
Clin Kidney J. 2024 Jun 14;17(7):sfae141. doi: 10.1093/ckj/sfae141. eCollection 2024 Jul.

本文引用的文献

1
Duration of Analgesic Use and Risk of Hearing Loss in Women.女性使用镇痛药的时长与听力损失风险
Am J Epidemiol. 2017 Jan 1;185(1):40-47. doi: 10.1093/aje/kww154. Epub 2016 Dec 14.
2
Predicting risk of adverse drug reactions in older adults.预测老年人药物不良反应的风险。
Ther Adv Drug Saf. 2016 Feb;7(1):11-22. doi: 10.1177/2042098615615472.
3
Hypertension, Diuretic Use, and Risk of Hearing Loss.高血压、利尿剂的使用与听力损失风险
Am J Med. 2016 Apr;129(4):416-22. doi: 10.1016/j.amjmed.2015.11.014. Epub 2015 Nov 30.
4
Classifying human audiometric phenotypes of age-related hearing loss from animal models.从动物模型中分类与年龄相关的听力损失的人类听力表型。
J Assoc Res Otolaryngol. 2013 Oct;14(5):687-701. doi: 10.1007/s10162-013-0396-x. Epub 2013 Jun 6.
5
Analgesic use and the risk of hearing loss in women.镇痛药的使用与女性听力损失的风险。
Am J Epidemiol. 2012 Sep 15;176(6):544-54. doi: 10.1093/aje/kws146. Epub 2012 Aug 29.
6
Cochlear implantation in older adults.老年人的人工耳蜗植入
Medicine (Baltimore). 2012 Sep;91(5):229-241. doi: 10.1097/MD.0b013e31826b145a.
7
Azithromycin for prevention of exacerbations of COPD.阿奇霉素预防 COPD 加重。
N Engl J Med. 2011 Aug 25;365(8):689-98. doi: 10.1056/NEJMoa1104623.
8
Antioxidant enzymes, presbycusis, and ethnic variability.抗氧化酶、老年性聋与种族差异。
Otolaryngol Head Neck Surg. 2010 Aug;143(2):263-8. doi: 10.1016/j.otohns.2010.03.024.
9
Analgesic use and the risk of hearing loss in men.男性镇痛药使用与听力损失风险。
Am J Med. 2010 Mar;123(3):231-7. doi: 10.1016/j.amjmed.2009.08.006.
10
Education, occupation, noise exposure history and the 10-yr cumulative incidence of hearing impairment in older adults.老年人的教育程度、职业、噪声暴露史与听力障碍的10年累积发病率
Hear Res. 2010 Jun 1;264(1-2):3-9. doi: 10.1016/j.heares.2009.10.008. Epub 2009 Oct 22.

老年人群听力损失与耳毒性药物的相关性。

The Contribution of Ototoxic Medications to Hearing Loss Among Older Adults.

机构信息

School of Nursing, University of California San Francisco.

School of Medicine and Public Health, University of Wisconsin-Madison.

出版信息

J Gerontol A Biol Sci Med Sci. 2020 Feb 14;75(3):561-566. doi: 10.1093/gerona/glz166.

DOI:10.1093/gerona/glz166
PMID:31282945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7328195/
Abstract

BACKGROUND

Ototoxicity may interact with the effects of aging, leading to a more severe hearing loss than that associated with age alone. The purpose of this study was to explore the associations between ototoxic medication use and the incidence and progression of hearing loss in older adults with a population-based longitudinal study.

METHODS

Epidemiology of Hearing Loss Study participants (n = 3,753) were examined. Medication use was assessed using a standardized questionnaire by the examiners at each examination every 5 year. The ototoxic medications include loop diuretics, nonsteroidal anti-inflammatory drugs, antibiotics, chemotherapeutic agents, quinine, and acetaminophen in this study. Generalized estimating equations model was used as a proportional hazard discrete time analysis.

RESULTS

Number of ototoxic medications was associated with the risk of developing hearing loss during the 10-year follow-up period (hazard ratio [HR] = 1.15, 95% confidence interval [CI] = 1.06, 1.25) after adjusting for age, sex, smoking, and body mass index. Loop diuretics (HR = 1.40, 95% CI = 1.05, 1.87) were associated with the 10-year incidence of hearing loss. Nonsteroidal anti-inflammatory drugs (HR = 1.45, 95% CI = 1.22, 1.72) and loop diuretics (HR = 1.33 95% CI = 1.08, 1.63) were associated with risk of progressive hearing loss over 10 years.

CONCLUSION

These ototoxic medications are commonly used in older adults and should be considered as potentially modifiable contributors to the incidence and severity of age-related hearing loss.

摘要

背景

耳毒性可能与衰老的影响相互作用,导致听力损失比单独与年龄相关的听力损失更严重。本研究的目的是通过一项基于人群的纵向研究,探讨老年患者使用耳毒性药物与听力损失的发生和进展之间的关系。

方法

对听力损失流行病学研究的参与者(n=3753)进行了检查。在每次每 5 年的检查中,由检查人员使用标准化问卷评估药物使用情况。在这项研究中,耳毒性药物包括利尿剂、非甾体抗炎药、抗生素、化疗药物、奎宁和对乙酰氨基酚。使用广义估计方程模型作为比例风险离散时间分析。

结果

在 10 年的随访期间,使用的耳毒性药物数量与发生听力损失的风险相关(危险比[HR]=1.15,95%置信区间[CI] = 1.06,1.25),调整年龄、性别、吸烟和体重指数后。利尿剂(HR=1.40,95%CI=1.05,1.87)与 10 年内听力损失的发生率相关。非甾体抗炎药(HR=1.45,95%CI=1.22,1.72)和利尿剂(HR=1.33,95%CI=1.08,1.63)与 10 年内听力损失的进展风险相关。

结论

这些耳毒性药物在老年人中广泛使用,应被视为与年龄相关听力损失的发生和严重程度相关的潜在可改变因素。